The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPennant International Regulatory News (PEN)

Share Price Information for Pennant International (PEN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 28.50
Bid: 28.00
Ask: 29.00
Change: 0.00 (0.00%)
Spread: 1.00 (3.571%)
Open: 28.50
High: 28.50
Low: 28.50
Prev. Close: 28.50
PEN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Major Programme Update

2 May 2019 07:00

RNS Number : 8241X
Pennant International Group PLC
02 May 2019
 

FOR IMMEDIATE RELEASE 02 May 2019

 

 

PENNANT INTERNATIONAL GROUP PLC

 

 

Major Programme Update

 

 

Pennant International Group plc ("Pennant", the "Company" or the "Group"), the AIM quoted supplier of integrated training and support solutions, products and services which train and assist operators and maintainers in the defence and regulated civilian sectors, provides an update on a potential contract award.

 

The Group has been down-selected on a major programme as announced on 9 August 2018. The Group has received notification that the placing of the Pennant contract is now contingent on the prospective customer's single-source 'upstream' contract becoming effective, which may not occur until the second half of 2020.

 

Pennant is engaging with the prospective customer with a view to accelerating the award and, as a result of the relationship established with the prospective customer, is also in discussions on a number of other opportunities.

 

The potential value of the contract to Pennant (£25 million to £30 million) remains unchanged.

 

Having initially received confirmation from the prospective customer that Pennant's contract would be awarded during the latter part of 2018 (with an aggressive timeline for delivery), the Group invested in expanding its operational capacity in order to deliver the contract (and other likely new programmes of work). Accordingly, while the Group is anticipating record revenues for 2019 (in the region of £22 million), costs are presently being incurred which would not otherwise have been (circa £90,000 per month) which is affecting operating margin. The Company will commence a cost-reduction exercise in response to this new timeframe for contract award.

 

The Board does not expect the potential delay in the contract award to have a material impact on market expectations for the current year and, having regard to the Group's pipeline of active opportunities, remains confident about the Company's prospects for the future.

 

 

 

 

Certain information contained in this announcement would have constituted inside information (as defined by Article 7 of Regulation (EU) No 596/2014) ("MAR") prior to its release as part of this announcement and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

 

 

Enquiries:

 

Pennant International Group plc

www.pennantplc.co.uk

Philip Walker, CEO

David Clements, Commercial & Risk Director

+44 (0) 1452 714 914

 

 

WH Ireland Limited

www.whirelandcb.com

Mike Coe

+44 (0) 117 945 3470

 

 

Walbrook PR (Financial PR)

paul.vann@walbrookpr.com

Paul Vann / Tom Cooper

+44 (0)20 7933 8780

+44 (0)7768 807631

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
CNTABMBTMBJMTML
Date   Source Headline
29th May 20125:48 pmRNSTransaction in Own Shares
25th May 201212:12 pmRNSTransaction in Own Shares
22nd May 201211:58 amRNSTransaction in Own Shares
15th May 201211:01 amRNSResult of AGM and GM
15th May 20127:00 amRNSTrading Statement
30th Apr 20125:12 pmRNSTransaction in Own Shares
5th Apr 20124:53 pmRNSDirector/PDMR Shareholding
2nd Apr 20122:55 pmRNSTransaction in Own Shares
2nd Apr 201210:46 amRNSPublication of Annual Report and Accounts/Circular
26th Mar 20127:00 amRNSFinal Results
10th Jan 201212:00 pmRNSTransaction in Own Shares
21st Dec 20111:28 pmRNSTransaction in Own Shares
21st Dec 20117:00 amRNSTrading Update
21st Oct 201111:53 amRNSTransaction in Own Shares
20th Sep 20112:31 pmRNSTransaction in Own Shares
15th Sep 20119:51 amRNSTreasury Stock
5th Sep 20117:00 amRNSHalf Yearly Report
17th May 201112:30 pmRNSAGM Statement
13th May 201110:32 amRNSTransaction in Own Shares
12th May 201112:49 pmRNSTransaction in Own Shares
6th May 20113:27 pmRNSTransaction in Own Shares
4th May 201112:55 pmRNSTransaction in Own Shares
28th Apr 20119:00 amRNSTransaction in Own Shares
21st Apr 201112:33 pmRNSTransaction in Own Shares
19th Apr 20111:37 pmRNSTransaction in Own Shares
13th Apr 201112:43 pmRNSPosting of Documents
30th Mar 201111:40 amRNSTransaction in Own Shares
28th Mar 20112:38 pmRNSTransaction in Own Shares
28th Mar 20117:00 amRNS2010 Final Results
22nd Mar 20117:00 amRNSRe Contract
4th Jan 20113:02 pmRNSChange of Registrars
8th Nov 201012:10 pmRNSDirectors incentivisation and Treasury Stock
5th Nov 20107:00 amRNSDirectorate Change
10th Sep 201012:24 pmRNSTransaction in Own Shares
9th Sep 20104:32 pmRNSHolding(s) in Company
6th Sep 20103:06 pmRNSTransaction in Own Shares
6th Sep 20107:00 amRNSHalf Yearly Report
14th Jul 201010:09 amRNSHolding(s) in Company
18th May 20101:01 pmRNSResult of AGM and GM
28th Apr 201011:10 amRNSHolding(s) in Company
13th Apr 20104:57 pmRNSPosting of Annual Report and Circular
29th Mar 20107:00 amRNSFinal Results
10th Mar 20107:00 amRNSSuccessful completion of Type 45 TMEC Warfare Pack
16th Feb 20107:00 amRNSNew Contract Award
11th Feb 201011:34 amRNSDividend Declaration (Replacement)
11th Feb 201010:32 amRNSDividend Declaration
11th Jan 20105:36 pmRNSTransaction in Own Shares
4th Jan 20102:25 pmRNSTransaction in Own Shares
17th Dec 200912:52 pmRNSDirector/PDMR Shareholding
1st Oct 200912:57 pmRNSIssue of Options and Option Amendments

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.